Form 4: CEL-SCI CEO Geert Kersten Increases Stake with Recent Stock Acquisition

CEL-SCI Corporation's Chief Executive Officer, Geert R. Kersten, has acquired 2,292 shares of common stock, increasing his direct beneficial ownership to 43,638 shares.

Summary

• Geert R. Kersten, Chief Executive Officer and Director of CEL-SCI Corp (CVM), acquired 2,292 shares of common stock.
• The transaction occurred on June 30, 2025, at a price of $2.29 per share.
• Following this acquisition, Mr. Kersten directly beneficially owns a total of 43,638 shares of CEL-SCI common stock.

Sentiment

Score: 8

Explanation: The acquisition of shares by the CEO is a strong positive signal, indicating management's confidence in the company's future performance and aligning their interests with shareholders.

Positives

• The Chief Executive Officer and Director, Geert R. Kersten, acquired additional shares, signaling confidence in the company's future prospects.
• The acquisition increases the CEO's direct beneficial ownership, aligning management's interests further with shareholders.

Future Outlook

NA

Industry Context

This insider purchase by the CEO of CEL-SCI Corp, a biotechnology company, suggests internal confidence, which is a common signal observed across various industries, particularly in sectors like biotech where R&D milestones and clinical trial outcomes heavily influence valuation.

Related Party Transactions

• Geert R. Kersten, as the Chief Executive Officer and Director, acquired common stock from the issuer, CEL-SCI Corp, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the CEO's stock acquisition as a positive indicator of management's belief in the company's value and future growth, potentially increasing investor confidence.

Key Dates

Recommendation

Keywords

CEL-SCI Corp, CVM, Geert Kersten, Insider Buying, Stock Acquisition, Beneficial Ownership, CEO, Director, SEC Form 4, Equity Securities